Jeremy Grantham Merck & Co., Inc. Transaction History
Grantham, Mayo, Van Otterloo & Co. LLC
- $30.8 Billion
- Q1 2025
A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 6,686,596 shares of MRK stock, worth $566 Million. This represents 1.95% of its overall portfolio holdings.
Number of Shares
6,686,596
Previous 6,165,271
8.46%
Holding current value
$566 Million
Previous $613 Million
2.14%
% of portfolio
1.95%
Previous 2.06%
Shares
32 transactions
Others Institutions Holding MRK
# of Institutions
3,888Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$21.4 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.2 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.92 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$5.05 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $215B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...